A detailed history of Hrt Financial LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 20,405 shares of IDYA stock, worth $566,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,405
Holding current value
$566,646
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.37 - $43.05 $619,699 - $878,435
20,405 New
20,405 $646,000
Q1 2023

May 12, 2023

BUY
$13.49 - $18.72 $573,824 - $796,292
42,537 New
42,537 $584,000
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $377,306 - $644,768
40,834 New
40,834 $609,000
Q2 2022

Aug 12, 2022

SELL
$8.28 - $13.88 $540,071 - $905,336
-65,226 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $729,226 - $1.57 Million
65,226 New
65,226 $729,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.33B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.